Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer.
about
Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients.Correlations of Hemoglobin Level and Perioperative Blood Transfusion with the Prognosis of Gastric Cancer: A Retrospective Study.The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trialClinical significance of coagulation factors in operable colorectal cancer.Analysis of lymph node metastasis correlation with prognosis in patients with T2 gastric cancer.Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen.Utility of plasma fibrinogen in the differential diagnosis of thyrotoxicosis.Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study.Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric CancerIdentification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast CancerSerum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.Preoperative plasma fibrinogen level is a useful predictor of adjacent organ involvement in patients with advanced gastric cancer.High plasma fibrinogen is correlated with poor response to trastuzumab treatment in HER2 positive breast cancer.A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia.Combined fibrinogen concentration and neutrophil-lymphocyte ratio as a prognostic marker of gastric cancer.Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer.Colorectal cancer and hypercoagulability.Plasma fibrinogen level may be a possible marker for the clinical response and prognosis of patients with breast cancer receiving neoadjuvant chemotherapy.Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohortsThe association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression.Combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients undergoing surgery for non-small cell lung cancer.Retrospective Proteomic Analysis of a Novel, Cancer Metastasis-Promoting RGD-Containing Peptide.High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma.Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer.Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment.Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer.Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer.Coagulation and fibrinolysis in gastric cancer.Role of patient-, tumor- and systemic inflammatory response-related factors in predicting survival of patients with node-negative gastric cancer.Impact of plasma fibrinogen levels in benign and malignant soft tissue tumors.Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma.Using a nomogram based on preoperative serum fibrinogen levels to predict recurrence of papillary thyroid carcinoma.Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer.Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG
P2860
Q33563950-B9337F55-6F7D-4EC3-BEC8-5F309313CD32Q33627109-BBB1475D-248A-4861-8F25-3C44EE94E222Q33744640-2F6E2FEF-B587-4015-B619-8795E5EB12F6Q33747342-D32CAF22-F861-4B82-81E4-E065AF31B9A7Q33750966-F5EE128D-0C59-49DA-A8AC-4C75CBA053FEQ34066534-C4686889-C260-44F9-813C-68D9D034FB92Q34361335-6CE1A8E1-D530-4559-87BE-C89EF41B5317Q35173816-3B87ECFA-0DE2-4BDD-BFF5-8D81B373474FQ35581934-C9B40A40-2D8F-4068-A8ED-5EE177178729Q35663782-12E121B1-0BA1-4823-AF18-EEC3CBACA793Q35867858-1F840FAE-DAAA-479B-9090-E6CB1AE6F181Q35901137-96E32E10-7C3A-476B-A81F-4119FD2E2173Q36078278-9B43E3ED-941C-442C-B4DB-DF9ACBE4EA9CQ36083601-17561A36-CF0F-4F79-821A-AE847AD85915Q36152165-CABFA5A4-8B6A-4DC8-A3C8-813FEDB1261FQ36513623-BB758A65-1DDD-4334-AEC7-E3EE31F48DCBQ36524772-446644DB-AD82-49A1-B4FF-2F1ACC6AE335Q37483472-EEC2F54F-60CC-4585-A045-0D0E1F943991Q38106603-3AA84586-281D-44FD-8262-D7096B6B2B33Q38722779-5CB5E96D-5451-4AF6-936D-C2017BB5C1B4Q39926759-4D00B4B9-8C6B-4ED6-9C36-24C217985D7AQ39965316-65E90BC3-D672-47FC-A6F7-01D72BFEDA79Q41577287-920F0327-7DD3-4F80-82F9-3D5ECA6C781CQ41708805-A0FF2946-9E8A-435F-83BC-7613DEFA5A3EQ41727394-24E0E7F0-0979-445E-A616-FF32E50F0963Q42161605-862079C7-7239-4ED4-8CE5-4243A4E0D94EQ42700678-40649E4E-6D71-4718-B2DF-0A54EA672E95Q43235061-A225A7A5-7C8F-4D02-A632-7D4A89758AE4Q44076202-349EB4EE-2CCD-4ED6-A519-A1FA37DD1AEDQ44335229-43851EF9-C71F-49E5-A45C-4BE6925A478FQ44597469-0262DDB3-6856-4169-98DE-380A55C320DAQ45119447-000A4A84-A1E4-4B17-AAE0-D5BEB8B43A83Q46420172-A8210E91-5E8D-4CA0-A97E-DF292D6B568CQ47916707-8A15906F-0C66-43D2-ADA5-7221A3F5B695Q50582885-010CA9BC-97D3-496A-9168-0C123B1C1D23Q53125747-0E271450-70C5-4B7F-8772-E8AA4A06E9F0Q55195821-E0C8BDCC-E174-41BB-8906-E601FBDF413CQ55411847-81EFD57F-474C-49F9-91A0-43247B28123EQ55505567-6045F7E8-7A81-4551-8774-9733E1B38534Q58792276-0D5857B2-A8EC-48F9-BEBF-946F94D3A245
P2860
Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hyperfibrinogenemia is associa ...... outcome in T2 gastric cancer.
@ast
Hyperfibrinogenemia is associa ...... outcome in T2 gastric cancer.
@en
type
label
Hyperfibrinogenemia is associa ...... outcome in T2 gastric cancer.
@ast
Hyperfibrinogenemia is associa ...... outcome in T2 gastric cancer.
@en
prefLabel
Hyperfibrinogenemia is associa ...... outcome in T2 gastric cancer.
@ast
Hyperfibrinogenemia is associa ...... outcome in T2 gastric cancer.
@en
P2093
P2860
P356
P1433
P1476
Hyperfibrinogenemia is associa ...... l outcome in T2 gastric cancer
@en
P2093
Hirokazu Nagawa
Joji Kitayama
Nobuko Kanno
P2860
P2888
P356
10.1186/1471-2407-6-147
P407
P577
2006-06-01T00:00:00Z
P5875
P6179
1032514911